Lv2
124 积分 2022-12-05 加入
COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
7天前
已完结
MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma
11天前
已关闭
Context-dependent cancer vulnerabilities: CRISPR screening under inflammatory stress
11天前
已完结
Engineering oral commensal nanovaccines to activate mucosal-systemic immune cascades against tumor
11天前
已完结
STING-mediated cancer immunotherapy: emerging modalities and beyond
11天前
已完结
Radiotherapy and tertiary lymphoid structures: balancing immune activation and immune damage in cancer immunotherapy
15天前
已完结
Remodeling of the tumor microenvironment in muscle-invasive bladder cancer: insights from single-cell and spatial transcriptomics after neoadjuvant immunochemotherapy
17天前
已完结
Leveraging Mitochondria-Endoplasmic Reticulum Functional Interplay With an On-Demand Nanoparticle to Boost mtDNA-Based STING Immunotherapy
17天前
已完结
Plasma Histidine Levels Predict Response to Immune Checkpoint Inhibition
17天前
已关闭
Stromal-Immune Interactions Promote Immune Suppression in Intraperitoneal Metastasis of Ovarian Carcinoma
17天前
已完结
皖公网安备34019202002308
